Rapid microbiology testing market set to be worth over $6 billion in 2026
Rising at a CAGR of 8.2 percent, the rapid microbiology testing market is predicted to grow over the next five years.
List view / Grid view
Rising at a CAGR of 8.2 percent, the rapid microbiology testing market is predicted to grow over the next five years.
EvaluateMedTech World Preview provides a range of insights into the expected performance of the medtech industry...
1 February 2016 | By Victoria White
Abbott has announced that it is to acquire Alere, significantly advancing Abbott's global diagnostics presence and leadership.